Gland Pharma Ltd (GLAND) — Announcement | 10 September 2026

10 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Gland Pharma announces schedule of analyst and institutional investor meetings

💡 Investor Takeaway

Investors should note the upcoming meetings may signal upcoming strategic updates or market sentiment shifts.

Gland Pharma announced its schedule of analyst and institutional investor meetings on September 10, 2026, listing one-on-one and group sessions with East Bridge Capital, IIFL Capital, Antique Broking, and a Nomura-arranged group meeting. The filings confirm the meeting dates and participants but provide no financial updates or guidance. Investors can expect direct engagement with key funds ahead of potential catalysts.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This

About Gland Pharma Ltd (GLAND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹49,299.85 CrP/E: 43.6ROE: 10.9%ROCE: 15.2%Div Yield: 0.67%

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

💡 Ask AI about this filing

"When will Gland Pharma share Q3 financial results?""What is the company's revenue growth outlook for FY27?""How does Gland Pharma's margin trend compare to peers?"

Ask AI Free →

📊 More GLAND filings

🟡 Board Meeting — 13 September 2026Gland Pharma's board addressed fines from NSE and BSE totaling **₹70,000 each** for a 34-day technic...
🔴 Corporate Action — 13 September 2026Gland Pharma announced on September 13, 2026, that its board approved acquiring 100% of Gland Pharma...
🟡 Board Meeting — 13 September 2026Gland Pharma announced on September 13, 2026 that its Board approved the grant of 5,90,249 stock opt...
🔴 Corporate Action — 13 September 2026Gland Pharma announced the allotment of 42,393 equity shares under ESOP 2025 and 1,800 shares under ...
🟡 Board Meeting — 13 September 2026Gland Pharma announced the board approved acquiring 100% of Gland Pharma USA Inc. for USD 5,01,208 i...

See all GLAND filings →

🔥 Also filed on 10 September 2026

KOLTEPATILKolte Patil Developers LtdAnnouncement IIFLIIFL Finance LtdCorporate Action BSHSLBombay Super Hybrid Seeds LtdAnnual Report JNPRJuniper Green Energy LtdAnnouncement SURYODAYSuryoday Small Finance Bank LtdAnnouncement SUPERSPINSuper Spinning Mills LtdInsider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.